Mitochondrial Oxidation and Insulin Resistance in Burn Patients Treated With Fenofibrate

NCT00732485 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Principal Investigator Changed

Conditions

Burn

Interventions

DRUG: fenofibrate
DRUG: placebo

Sponsor

The University of Texas Medical Branch, Galveston

Collaborators

[object Object]